K. Tsuchikama

Protein & Cell · 2016

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom K. Tsuchikama trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Postow

Papers from K. Tsuchikama's perspective

Ordered by how strongly the researchers K. Tsuchikama trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. (New England Journal of Medicine)
  2. A history of cancer chemotherapy. (Cancer Research)
  3. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index (Nature Biotechnology)
  4. Glutathione metabolism and its implications for health. (Journal of NutriLife)
  5. Immune Checkpoint Blockade in Cancer Therapy. (Journal of Clinical Oncology)
  6. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. (Advanced Drug Delivery Reviews)
  7. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. (Journal of Clinical Oncology)
  8. Antibody-drug conjugates: an emerging concept in cancer therapy. (Angewandte Chemie)
  9. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer (New England Journal of Medicine)
  10. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. (New England Journal of Medicine)

Their papers